Based on the federal notice and prior regulatory filings, the substances under consideration are drawn from the broader list of peptides that were placed on the Category 2 restricted list beginning in 2023
Here is what matters: aim the needle at the glass wall of the vial, not directly at the lyophilized powder cake at the bottom
1f, with area under the curve, AUC), food intake on refeeding after the i.p
Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026
The results of a global phase III clinical trial offered to head and neck cancer patients at Providence Cancer Institute were published in the New England Journal of Medicine